Agenus sells manufacturing assets to Zydus for $75M upfront; license BOT/BAL in India

AGENUS INC

Asset sale of Emeryville/ Berkeley CA facilities for $75M at closing; up to $50M additional contingent payments.
Exclusive license to Zydus for BOT/BAL in India and Sri Lanka; 5% royalty on net sales.
Zydus makes $16M equity investment at $7.50/share (approx. 2.1M shares); 12-month lockup.
Transaction includes contract manufacturing agreement; proceeds to fund BOT/BAL development.
Parties aim to close within 60 days, subject to customary conditions and government approvals.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.